<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04172025</url>
  </required_header>
  <id_info>
    <org_study_id>2019-01291; qu19Egli5</org_study_id>
    <nct_id>NCT04172025</nct_id>
  </id_info>
  <brief_title>Development of a Swiss Surveillance Database for Molecular Epidemiology of Hypervirulent and Multi-drug Resistant Pathogens</brief_title>
  <official_title>Development of a Swiss Surveillance Database for Molecular Epidemiology of Hypervirulent and Multi-drug Resistant Pathogens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss National Science Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypervirulent and multidrug-resistant infections are associated with significant health care
      costs, substantial morbidity and mortality. Therefore, the rapid recognition of outbreaks and
      transmissions with hypervirulent and multi-drug resistant pathogen is a key priority for
      infection control and public health.The main goal is to implement a shared database,
      connecting human and veterinary microbiology laboratories, which would allow near real-time
      molecular epidemiology with high spatiotemporal resolution of bacterial pathogens such as
      transmission and outbreak surveillance between different compartments including humans,
      animals and the environment in Switzerland. Investigator aims to analyze already collected
      encoded retrospective datasets of various pathogens by combining epidemiological data and
      whole genome sequences from pathogens.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypervirulent and multidrug-resistant infections are associated with significant health care
      costs, substantial morbidity and mortality. Therefore, the rapid recognition of outbreaks and
      transmissions with hypervirulent and multi-drug resistant pathogen is a key priority for
      infection control and public health. For hospital epidemiologist, infectious disease and
      public health experts, and microbiologists the identification of an outbreak source is a
      first important step to establish effective counter-measurements. In Switzerland, the burden
      of pathogen transmission between humans, animals and the environment is substantial. The main
      goal is to implement a shared database, connecting human and veterinary microbiology
      laboratories, which would allow near real-time molecular epidemiology with high
      spatiotemporal resolution of bacterial pathogens such as transmission and outbreak
      surveillance between different compartments including humans, animals and the environment in
      Switzerland. Investigator aims to analyze already collected encoded retrospective datasets of
      various pathogens by combining epidemiological data and whole genome sequences from
      pathogens.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 30, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of transmission clusters based on genetic similarity.</measure>
    <time_frame>Onetime identification at baseline</time_frame>
    <description>Identification of transmission clusters based on genetic similarity. With focus on whole genome sequencing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection of Genotypic Resistance</measure>
    <time_frame>Onetime identification at baseline</time_frame>
    <description>Detection of Genotypic Resistance (in-vitro antibiotic susceptibility test (AST) based on measuring minimum inhibitory concentration (MIC) or zone diameter (ZD))</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Multiresistant Bacterial Pathogens</condition>
  <condition>Virulent Bacterial Pathogens</condition>
  <arm_group>
    <arm_group_label>Patients with colonization or infections with a pathogen</arm_group_label>
    <description>All patients with either colonisations or infections with either a bacterial or a viral pathogen, where whole genome sequencing data and available minimal epidemiological, demographic and clinical data</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Analysis of Bacterial Genome</intervention_name>
    <description>genome assembly; prediction of sequence type (MLST); core genome MLST tree to rapidly compare strains within a project; core genome single nucleotide polymorphism (SNP) tree to compare all Swiss Pathogen Surveillance Platform (SPSP) strains belonging to a same species; whole genome SNP tree to compare all SPSP strains within the same species and ST;; prediction of resistance and virulence factors within pathogen submitted genomes; time trees and calculation of transmission rates, including basic reproduction number; analysis of classical epidemiological data with advanced statistical methods including machine learning.</description>
    <arm_group_label>Patients with colonization or infections with a pathogen</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        • All patients with either colonisations or infections with either a bacterial or a viral
        pathogens including the below listed pathogens from participating centers in Switzerland.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with either colonisations or infections with either a bacterial or a
             viral pathogen, where whole genome sequencing data and available minimal
             epidemiological, demographic and clinical data

          -  Pathogens included into analysis are: Multidrug-resistant bacteria include:
             methicillin resistant Staphylococcus aureus (MRSA), Carbapenemase- and/or extended
             spectrum betalactamase (ESBL)-producing Enterobacteriaceae and non-fermenting bacteria
             including Pseudomonas aeruginosa and Acinetobacter baumannii, Vancomycin resistant
             Enterococcus faecium, and others; virulent bacteria include: Neisseria meningitidis,
             Neisseria gonorrhoeae, Mycobacterium tuberculosis, Campylobacter spp., Salmonella
             spp., Legionella pneumophila, Listeria monocytogenes, and Streptococcus pneumoniae,
             and others; Viruses include: Influenza viruses, Measles virus, Enterovirus E68,
             Respiratory Syncytial Virus and others.

        Exclusion Criteria:

          -  Decline to sign a general consent or any other declining statement against using data
             for research purposes.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrian Egli, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Biozentrum, University of Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adrian Egli, MD PhD</last_name>
    <phone>+41 61 556 5749</phone>
    <email>adrian.egli@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Richard Neher</last_name>
    <email>Richard.Neher@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of Microbiology CHUV</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilbert Greub, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service of Hospital Preventive Medicine CHUV</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Blanc, P.D. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Bacteriology and Mycology</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrian Egli, MD PhD</last_name>
      <phone>+41 61 556 5749</phone>
      <email>adrian.egli@usb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Richard Neher, Prof</last_name>
      <email>Richard.Neher@usb.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Institute of Veterinary Bacteriology</name>
      <address>
        <city>Bern</city>
        <zip>3012</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Perreten, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bacteriology Laboratory, Universität Geneva</name>
      <address>
        <city>Geneva</city>
        <zip>1205</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques Schrenzel, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute for Foodsafety and -hygiene, VetSuisse</name>
      <address>
        <city>Zürich</city>
        <zip>8057</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roger Stephan, Prof</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, Ouakrim DA, Oliveira TC, Struelens MJ, Suetens C, Monnet DL; Burden of AMR Collaborative Group. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019 Jan;19(1):56-66. doi: 10.1016/S1473-3099(18)30605-4. Epub 2018 Nov 5.</citation>
    <PMID>30409683</PMID>
  </reference>
  <reference>
    <citation>Daxboeck F, Budic T, Assadian O, Reich M, Koller W. Economic burden associated with multi-resistant Gram-negative organisms compared with that for methicillin-resistant Staphylococcus aureus in a university teaching hospital. J Hosp Infect. 2006 Feb;62(2):214-8. Epub 2005 Oct 27.</citation>
    <PMID>16257092</PMID>
  </reference>
  <reference>
    <citation>Egli A, Blanc DS, Greub G, Keller PM, Lazarevic V, Lebrand A, Leib S, Neher RA, Perreten V, Ramette A, Schrenzel J, Stephan R, Wagner K, Wuethrich D, Xenarios I. Improving the quality and workflow of bacterial genome sequencing and analysis: paving the way for a Switzerland-wide molecular epidemiological surveillance platform. Swiss Med Wkly. 2018 Dec 15;148:w14693. doi: 10.4414/smw.2018.14693. eCollection 2018 Dec 3.</citation>
    <PMID>30552858</PMID>
  </reference>
  <reference>
    <citation>Ford L, Carter GP, Wang Q, Seemann T, Sintchenko V, Glass K, Williamson DA, Howard P, Valcanis M, Castillo CFS, Sait M, Howden BP, Kirk MD. Incorporating Whole-Genome Sequencing into Public Health Surveillance: Lessons from Prospective Sequencing of Salmonella Typhimurium in Australia. Foodborne Pathog Dis. 2018 Mar;15(3):161-167. doi: 10.1089/fpd.2017.2352. Epub 2018 Jan 16.</citation>
    <PMID>29336594</PMID>
  </reference>
  <reference>
    <citation>Meinel DM, Kuehl R, Zbinden R, Boskova V, Garzoni C, Fadini D, Dolina M, Blümel B, Weibel T, Tschudin-Sutter S, Widmer AF, Bielicki JA, Dierig A, Heininger U, Konrad R, Berger A, Hinic V, Goldenberger D, Blaich A, Stadler T, Battegay M, Sing A, Egli A. Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing. Clin Microbiol Infect. 2016 Dec;22(12):1003.e1-1003.e8. doi: 10.1016/j.cmi.2016.08.010. Epub 2016 Aug 30.</citation>
    <PMID>27585943</PMID>
  </reference>
  <reference>
    <citation>Phodha T, Riewpaiboon A, Malathum K, Coyte PC. Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in Thailand. Expert Rev Pharmacoecon Outcomes Res. 2019 Jun;19(3):305-312. doi: 10.1080/14737167.2019.1537123. Epub 2018 Oct 19.</citation>
    <PMID>30321493</PMID>
  </reference>
  <reference>
    <citation>Seth-Smith HMB, Casanova C, Sommerstein R, Meinel DM, Abdelbary MMH, Blanc DS, Droz S, Führer U, Lienhard R, Lang C, Dubuis O, Schlegel M, Widmer A, Keller PM, Marschall J, Egli A. Phenotypic and Genomic Analyses of Burkholderia stabilis Clinical Contamination, Switzerland. Emerg Infect Dis. 2019 Jun;25(6):1084-1092. doi: 10.3201/eid2506.172119.</citation>
    <PMID>31107229</PMID>
  </reference>
  <reference>
    <citation>Sommerstein R, Führer U, Lo Priore E, Casanova C, Meinel DM, Seth-Smith HM, Kronenberg A, On Behalf Of Anresis, Koch D, Senn L, Widmer AF, Egli A, Marschall J, On Behalf Of Swissnoso. Burkholderia stabilis outbreak associated with contaminated commercially-available washing gloves, Switzerland, May 2015 to August 2016. Euro Surveill. 2017 Dec;22(49). doi: 10.2807/1560-7917.ES.2017.22.49.17-00213.</citation>
    <PMID>29233255</PMID>
  </reference>
  <reference>
    <citation>Stucki D, Ballif M, Egger M, Furrer H, Altpeter E, Battegay M, Droz S, Bruderer T, Coscolla M, Borrell S, Zürcher K, Janssens JP, Calmy A, Mazza Stalder J, Jaton K, Rieder HL, Pfyffer GE, Siegrist HH, Hoffmann M, Fehr J, Dolina M, Frei R, Schrenzel J, Böttger EC, Gagneux S, Fenner L. Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country. J Clin Microbiol. 2016 Jul;54(7):1862-1870. doi: 10.1128/JCM.00126-16. Epub 2016 May 18.</citation>
    <PMID>27194683</PMID>
  </reference>
  <reference>
    <citation>Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD, van der Werf MJ, Kranzer K, Fiebig L, Kröger S, Haas W, Hoffmann H, Indra A, Egli A, Cirillo DM, Robert J, Rogers TR, Groenheit R, Mengshoel AT, Mathys V, Haanperä M, Soolingen DV, Niemann S, Böttger EC, Keller PM; MDR-TB Cluster Consortium. A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. Lancet Infect Dis. 2018 Apr;18(4):431-440. doi: 10.1016/S1473-3099(18)30004-5. Epub 2018 Jan 8. Erratum in: Lancet Infect Dis. 2018 Jan 10;:.</citation>
    <PMID>29326013</PMID>
  </reference>
  <reference>
    <citation>Ward DV, Hoss AG, Kolde R, van Aggelen HC, Loving J, Smith SA, Mack DA, Kathirvel R, Halperin JA, Buell DJ, Wong BE, Ashworth JL, Fortunato-Habib MM, Xu L, Barton BA, Lazar P, Carmona JJ, Mathew J, Salgo IS, Gross BD, Ellison RT. Integration of genomic and clinical data augments surveillance of healthcare-acquired infections. Infect Control Hosp Epidemiol. 2019 Jun;40(6):649-655. doi: 10.1017/ice.2019.75. Epub 2019 Apr 23.</citation>
    <PMID>31012399</PMID>
  </reference>
  <reference>
    <citation>Wassilew N, Seth-Smith HM, Rolli E, Fietze Y, Casanova C, Führer U, Egli A, Marschall J, Buetti N. Outbreak of vancomycin-resistant Enterococcus faecium clone ST796, Switzerland, December 2017 to April 2018. Euro Surveill. 2018 Jul;23(29). doi: 10.2807/1560-7917.ES.2018.23.29.1800351. Erratum in: Euro Surveill. 2018 Jul;23(30):.</citation>
    <PMID>30043725</PMID>
  </reference>
  <reference>
    <citation>Wüthrich D, Gautsch S, Spieler-Denz R, Dubuis O, Gaia V, Moran-Gilad J, Hinic V, Seth-Smith HM, Nickel CH, Tschudin-Sutter S, Bassetti S, Haenggi M, Brodmann P, Fuchs S, Egli A. Air-conditioner cooling towers as complex reservoirs and continuous source of Legionella pneumophila infection evidenced by a genomic analysis study in 2017, Switzerland. Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1800192.</citation>
    <PMID>30696527</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 19, 2019</study_first_submitted>
  <study_first_submitted_qc>November 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>December 4, 2019</last_update_submitted>
  <last_update_submitted_qc>December 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Epidemiology</keyword>
  <keyword>surveillance</keyword>
  <keyword>bacterial pathogens</keyword>
  <keyword>Database</keyword>
  <keyword>Genotyping</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

